Kyle Diamantas Named Acting FDA Commissioner Following Marty Makary’s Resignation
- Marty Makary resigned from his position as commissioner of the US Food and Drug Administration (FDA) on May 12, 2026.
- Donald Trump confirmed the leadership change on May 12, 2026.
- Diamantas previously served as the top food official at the agency, where he was responsible for setting the operations and strategic direction for food policy in the United...
Marty Makary resigned from his position as commissioner of the US Food and Drug Administration (FDA) on May 12, 2026. Following the resignation, Kyle Diamantas will serve as the acting FDA commissioner.
Donald Trump confirmed the leadership change on May 12, 2026. In a post on Truth Social, Trump announced that Diamantas would be the temporary replacement for Makary, describing Diamantas as a very talented person
.
Diamantas previously served as the top food official at the agency, where he was responsible for setting the operations and strategic direction for food policy in the United States.
Makary’s tenure at the regulatory agency lasted 13 months. During this time, his leadership frequently drew criticism from the public, industry representatives, Congress, and the White House.
The resignation follows clashes between Makary and Trump regarding the regulation of fruit-flavored vapes.